510(k) DEN170010

LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay by Lin-Zhi International, Inc. — Product Code QBK

DEN170010 is an FDA 510(k) premarket notification submitted by Lin-Zhi International, Inc. for the device "LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay". The FDA issued a decision of De Novo granted on Apr 20, 2018. The device falls under product code QBK (Meprobamate Test System), a Class II device regulated under 21 CFR 862.3590. Lin-Zhi International, Inc. has 49 other 510(k) clearances on record.

Clearance details

Decision
DENG (De Novo granted)
Decision Date
Apr 20, 2018
Date Received
Feb 21, 2017
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Meprobamate Test System
Device Class
Class II
Regulation Number
862.3590
Review Panel
TX
Submission Type
510(k)

A meprobamate test system is a device intended to measure meprobamate in human specimens. Measurements obtained by this device are used to detect the presence of meprobamate to diagnose the use or overdose of meprobamate or structurally-related drug compounds (e.g., prodrugs).

Need the full FDA record for Lin-Zhi International, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for DEN170010. Report a data issue: hello@regdatalab.com.